We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Horizon Discovery Group Plc | LSE:HZD | London | Ordinary Share | GB00BK8FL363 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 184.50 | 184.50 | 185.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/11/2015 08:14 | Lets hope this is the start of the long climb back! Thought there may have been a holding RNS this morning as clearly a huge chunk of shares changed hands | cumbrian2 | |
10/11/2015 08:13 | Well I was quoted 135p to buy today, so had em on the spreads instead. edit: That was when the spread was 127-131 at 8:04 | phowdo | |
10/11/2015 08:13 | There we go. | small crow | |
10/11/2015 07:42 | Interesting day ahead, probably. | small crow | |
09/11/2015 18:20 | Massive clearup today . Bough some. Investor roadshow end of last week to make buyers. Should see £1.50 hopefully | maccamcd | |
09/11/2015 16:41 | Volume = 15m..... | deltrotter | |
09/11/2015 16:41 | Volume = 15% of the total shares in issue and nearly 25% of the free float, which is massive. Expecting some interesting RNS in the next 24 hours. | mamcw | |
09/11/2015 16:31 | Yeah, hopefully the seller being cleared.... | deltrotter | |
09/11/2015 16:28 | Some fairly chunky volume today - hopefully the beginning of the end to a miserable share price performance over the last 6 months. | mamcw | |
09/11/2015 10:08 | Thanks cestnous - been another disaster for them so far. I will give it a lot more time, although I would have preferred to be buying at these levels rather than my 180p average. Don't suppose it will matter in 5 years - which is my timeframe for this type of stock.... | deltrotter | |
09/11/2015 10:01 | Not in SCSW del | cestnous | |
09/11/2015 08:20 | Was there a tip update in SCSW at the weekend? Judging by the trades someone has mentioned them.... | deltrotter | |
28/10/2015 17:28 | Broker upbeat on HZD - today: | deltrotter | |
28/10/2015 16:21 | Big trades - seller cleared perhaps. | deltrotter | |
28/10/2015 09:17 | I got stopped out around 150p when I raised my stop on last good news. Looking for re-entry once the persistent drip-drip-drip of IPO sellers abates. | phowdo | |
28/10/2015 07:05 | An RNS hastily issued to try and shore up this collapsing price. That's the thing about these jam tomorrow shares - in uneasy markets they get hit. The chart looks awful so have sold up and happy to stand aside for the time being. | essential | |
27/10/2015 22:10 | Big seller still offloading IMO. Note the 100k trade today. | deltrotter | |
27/10/2015 21:34 | With the recent newsflow price going opposite way. Where will it rebound. Any reasons for price action or just what is normal for loss making AIM stock. | jugu | |
27/10/2015 17:11 | Swift Biosciences - another partnership | mirandaj | |
27/10/2015 15:20 | It'll come back IMO essential. | deltrotter | |
27/10/2015 14:35 | No buyers at all. Can only sell 500 at a time and that pushes the price lower. | essential | |
15/10/2015 09:11 | From "Shares" today; LIFE SCIENCES TOOLS and services provider Horizon Discovery (HZD:AIM) has signed a deal that could see it pocket £50 million in milestone payments. Agreeing to develop compounds discovered by French pharmaceutical Servier could also put the £136.9 million cap in line for royalties on any future product sales stemming from the research. Horizon will use its gene editing, drug combination screening expertise and cell building platform to evaluate the compounds to identify cancer patients most likely to respond to therapy. Servier has the option of buying the compounds back from Horizon, but if it doesn’t then Horizon is free to find another partner to sell any products resulting from its work. Analysts at N+1 Singer have not altered their forecasts and expect revenues to grow by 68% to £20 million in 2015. Less positively, pretax losses will almost double to £10.2 million during the year. SHARES SAYS:ST Horizon shows how drug companies’ share prices can fall on a lack of newsflow, but the newly signed agreement has potential. (MD) H | cestnous | |
14/10/2015 09:14 | My only disappointing stock atm (luckily). Out of favour now and no point in selling at this price. lets just hope the chart repeats itself as I can see no company specific reason for the poor price performance. Just imo. | cestnous |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions